AMANDA A HUSSEIN
Allopathic & Osteopathic Physicians|Family Medicine KISSIMMEE, FL NPI 1518528124
Browse related groups: Allopathic & Osteopathic Physicians|Family Medicine FL Novo Nordisk AS All categories
General Payments — all program years on this page
$212.19
- Category: General Payments
- Program years: PY2019–2024
- Record count: 11
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $160.43 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $160.43 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $65.46 | 3 |
| Acerta Pharma LLC | $30.28 | 2 |
| Sumitomo Pharma America, Inc. | $25.85 | 1 |
| Abbott Laboratories | $19.81 | 1 |
| Lilly USA, LLC | $19.03 | 1 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1096761547 | Novo Nordisk Inc | $24.40 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1096838075 | Novo Nordisk Inc | $16.46 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1097138355 | Novo Nordisk Inc | $24.60 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1104251913 | AstraZeneca Pharmaceuticals LP | $14.81 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1105205464 | AstraZeneca Pharmaceuticals LP | $15.47 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1125106319 | Abbott Laboratories | $19.81 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1136028879 | Lilly USA, LLC | $19.03 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1148867205 | Sumitomo Pharma America, Inc. | $25.85 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.